ABIM Council

Expand All | Collapse All

Asher A. Tulsky, MD, Chair

Dr. Tulsky is a board certified internist. He is Associate Professor of Medicine at the Boston University School of Medicine and Associate Chief of Education in the section of General Internal Medicine. His career has focused on postgraduate medical education, and he is currently Director of Resident Development at Boston Medical Center in Massachusetts.

Previously, he was Associate Program Director at the University of Pittsburgh Internal Medicine Residency program, directed their community-based residency program, established and directed the International Scholars Program for gifted and accomplished international medical graduates pursuing academic medicine careers and was the principal consultant in a collaboration between the University of Pittsburgh and the Teine Keijinkai Hospital in Sapporo, Japan, in establishing a U.S.-modeled internal medicine residency program.

Dr. Tulsky is the chair of Internal Medicine's (ABIM) Council, he is also Chair of the ABIM Internal Medicine Specialty Board and served for eight years on the ABIM Internal Medicine Board Exam Committee. He is also an active member of the Association of Program Directors of Internal Medicine.

Dr. Tulsky earned his medical degree from the Chicago Medical School in Illinois, completed internal medicine residency training at the Michael Reese Hospital and Medical Center, also in Chicago, and fellowship in general internal medicine at the University of Rochester School of Medicine and Dentistry in New York.

As of July 2021, Dr. Tulsky reported no ongoing external relationships.

Ashok Balasubramanyam, MD

Dr. Balasubramanyam, a board-certified internist and endocrinologist, is Professor of Medicine, Rutherford Professor of Diabetes Research and Vice President for Academic Integration at Baylor College of Medicine. His academic career has involved basic and translational research, education (as past director of the Endocrine Fellowship Program and currently of Baylor’s Clinical Scientist Training Program) and clinical service.

Dr. Balasubramanyam is a member of the ABIM Council and the Chair of the Endocrinology, Diabetes, and Metabolism Board of the American Board of Internal Medicine. He is a past president of the Association of Program Directors in Endocrinology and Metabolism. 

Dr. Balasubramanyam earned his undergraduate degree at Yale University and his medical degree at St. John’s Medical College, Bangalore, India. He completed internal medicine residency training and was Chief Resident at Baylor College of Medicine, and completed clinical and research fellowship training in endocrinology at the Massachusetts General Hospital, Boston.

As of July 2021, Dr. Balasubramanyam reported the following external relationships:

Work as an author or editor for the following company, with compensation as listed below:

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with honoraria:

• Catalys Pacific, for advice regarding clinical trial design for a new hypertension drug.

Work as an author or editor for the following company, with compensation as listed below:

• UpToDate^®,  receiving compensation for authorship on ketosis-prone diabetes.

Dr. Balasubramanyam serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

• Harris County Medical Society, Board Member, without compensation.

Laura Dingfield, MD

Dr. Dingfield is Assistant Professor of Clinical Medicine at the Perelman School of Medicine at the University of Pennsylvania, Director of Palliative Care Education for the University of Pennsylvania Health System, and Program Director of the Hospice and Palliative Medicine Fellowship at the University of Pennsylvania in Philadelphia. She is board certified in Internal Medicine, Pediatrics, and Hospice and Palliative Medicine. Her academic focus is on medical education, including curricular innovation and assessment in competency-based education programs.

Dr. Dingfield serves on the American Academy of Hospice and Palliative Medicine (AAHPM) Fellowship Training Committee, the AAHPM Assessment Task Force, and has previously served on Test Materials Development Committees for the National Board of Medical Examiners.

Dr. Dingfield graduated from the University of Michigan Medical School in Ann Arbor. She completed her internal medicine-pediatrics residency at the Hospital of the University of Pennsylvania-Children’s Hospital of Philadelphia, and her hospice and palliative medicine fellowship at the University of Pennsylvania Health System, also in Philadelphia. She holds a master’s degree in education from the University of Pennsylvania Graduate School of Education.

As of October 2021, Dr. Dingfield reported the following external relationships:

Grant funding for staff and expenses, paid to the Perelman School at the University of Pennsylvania, from the following organizations:

• Josiah Macy Jr. Foundation
• Berkman Charitable Trust

Laura Evans, MD, MSc, Chair-Elect

Dr. Evans is a Professor of Medicine at the University of Washington and the Medical Director of Critical Care at the University of Washington Medical Center in Seattle. She is board certified in Critical Care Medicine, Internal Medicine, Hospice and Palliative Medicine and Pulmonary Disease. Her interests focus on education, patient safety and quality improvement in the intensive care unit, particularly around sepsis.

She joined the Critical Care Medicine Board of the American Board of Internal Medicine in 2014. She has served as the Chair of the Internal Medicine Section of the Society of Critical Care Medicine and served on the Guidelines Oversight Committee of the American College of Chest Physicians. She currently serves as the Surviving Sepsis Campaign Guidelines co-Chair on the Council of the Society of Critical Care Medicine.

Dr. Evans earned her medical degree at the University of Michigan and completed her internal medicine residency at Columbia University. She completed pulmonary and critical care medicine fellowship training and earned a master of science degree in epidemiology at the University of Washington.

As of June 2022, Dr. Evans reported the following external relationships:

Work as an author or editor for following company, with compensation as listed:

• Elsevier, receiving compensation for authorship for textbook for medical students.

Dr. Evans serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

• Society of Critical Care Medicine, Surviving Sepsis Campaign Guidelines, co-Chair, COVID-19 Management Guidelines, co-Chair; Council, Member, without compensation.

Grant funding for salary support, paid to the University of Washington Medical Center, from the following organizations:

• CDC Foundation, serving as a Principal Investigator for a study of severe acute respiratory infection, including COVID-19, in hospitalized patients.
• National Emerging Special Pathogens Training and Education Center.

Erica N. Johnson, MD, Council Director

Dr. Johnson is Assistant Professor of Medicine in the Division of Infectious Diseases at Johns Hopkins University School of Medicine and the Program Director for the Internal Medicine Residency at Johns Hopkins Bayview Medical Center in Baltimore, Maryland. She is board certified in Internal Medicine and Infectious Disease and is a fellow of the American College of Physicians and the Infectious Disease Society of America.

In 2014, Dr. Johnson completed an 11-year career in the U.S. Army Medical Corps, where she served as the Associate Program Director for the Internal Medicine Residency and Infectious Disease Fellowship Programs in the San Antonio Uniformed Services Health Education Consortium. She also served as a clinical investigator with the Infectious Disease Clinical Research Program.

Dr. Johnson is the Chair of the American Board of Internal Medicine (ABIM) Infectious Disease Board and ABIM Council member. She is active in the Academic Alliance of Internal Medicine and the Infectious Diseases Society of America. She also co-directs the annual Johns Hopkins Infectious Disease Update Course for Primary Care and Hospital Medicine. Dr. Johnson has been recognized with numerous research, teaching and community service awards, including the San Antonio Uniformed Services Health Education Consortium Lieutenant General PK Carlton Outstanding Faculty Award; the Women of Color Science, Technology, Engineering and Math Conference Technology Rising Star Award; and the C. Lockard Conley Award for Teaching Excellence from the Maryland Chapter of the American College of Physicians.

Dr. Johnson received her bachelor’s degree in classics from the University of Virginia in Charlottesville, Virginia, and her medical degree from the University of Maryland in Baltimore, Maryland. She completed a residency in internal medicine at Walter Reed Army Medical Center in Washington, DC, and a fellowship in infectious disease at Brooke Army Medical Center in San Antonio, Texas.

As of August 2021, Dr. Johnson reported the following external relationships:

Dr. Johnson serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

• Infectious Diseases Society of America, Member of Medical Education Community of Practice Infectious Disease Week Workgroup.

Salahuddin Kazi, MD

Dr. Kazi, a board certified internist and rheumatologist, is the Vice Chair of Education for the Department of Internal Medicine and a Professor of Medicine in the Division of Rheumatic Diseases at University of Texas (UT) Southwestern Medical Center in Dallas. He is also the Director of the Internal Medicine Residency Training Program at UT Southwestern. Dr. Kazi is the Chair of the American Board of Internal Medicine Rheumatology Board. Dr. Kazi previously served as the Chair of the Registries and Health Information Technology Committee of the American College of Rheumatology overseeing the development of the RISE registry. Dr. Kazi continues to lead efforts in rheumatology to promote improvement in the delivery of healthcare through the principles of co-production.

Dr. Kazi earned his medical degree from Dow Medical College in Karachi, Pakistan, and completed his residency, chief residency, and fellowship in rheumatology at the University of Texas Health Science Center in Houston.

As of July 2021, Dr. Kazi reported no external relationships. 

Tommye Lambert, DMin, MDiv

Dr. Lambert is the mother and life-long caregiver to her daughter, Amy Crews, who passed away at age twenty-eight from complications associated with cystic fibrosis and lung transplantation. During that time, she interacted with pulmonary care clinicians and health care professionals at five centers, including critical care and transplant teams. She is a leader in the patient and caregiver community providing training and facilitating discussions focused on assisting in improved patient care through patient-doctor communication and collaboration. She serves as a public/patient member on the American Board of Internal Medicine (ABIM) Council.

Dr. Lambert is active with the National Cystic Fibrosis Foundation (CFF). She serves on the Palliative Care Guidelines Committee, as a CFF MiniCon panelist, as a parent/patient advocate, as a legislative forum volunteer, and has been active in annual fundraising activities for CFF for more than 30 years. Dr. Lambert advocates for organ donation by speaking and fundraising through Legacy of Hope, formerly Alabama Organ Center.

Professionally, Dr. Lambert is a member of the clergy at Hunter Street Baptist Church in Birmingham AL where she serves as the Manager of the Home Front Resource Center. She also serves on the Advisory Board of Shepherd’s Fold, a re-entry program for those transitioning from incarceration and on the Alumni Advisory Board for Beeson Divinity School at Samford University in Birmingham, Alabama.

Dr. Lambert earned a doctorate in ministry and a master's degree in divinity from Beeson Divinity School, Samford University in Birmingham. She earned a bachelor's degree in medical technology from the University of Southern Mississippi in Hattiesburg, Mississippi.

As of May 2022, Ms. Lambert reported the following ongoing external relationships:

Ms. Lambert serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

• Cystic Fibrosis Foundation, Palliative Care Guidelines Committee, Alabama Chapter Member, without compensation.
• Alabama Health Needs Advocacy Group, Cystic Fibrosis and Other Lung Diseases representative, without compensation.

Julianne Morath, RN

Ms. Morath is an international consultant in patient safety and healthcare quality leadership. Her work focuses on creating cultures of safety and designing reliability into clinical practice and the structures and mechanisms that support patient care. She is noted for her work in promoting workforce engagement and interdisciplinary alignment, and patient, family, and community advocacy.

Ms. Morath has served in executive positions and academic appointments at the University of Cincinnati, Brown University and Vanderbilt University Academic Medical Centers. Her executive experience also includes Children's Hospitals and Clinics of Minnesota; Allina Health System, and founding the Hospital Quality Institute, supporting more than 400 California hospitals and health systems. She is a founding and current member of the Lucian Leape Institute of the National Patient Safety Foundation and serves as faculty at the Institute for Healthcare Improvement.

Ms. Morath served as a member of the Board of Commissioners of The Joint Commission. She holds current appointments on multiple governing and advisory boards, including the Collaborative for Accountability and Improvement, Center for Scholarship Quality and Patient Safety, University of Washington School of Medicine, MedStar Quality and Patient Safety Institute Advisory Board, and Board of Trust, Virginia Mason Medical Center and Health Care System.

She was the inaugural recipient of the John Eisenberg Award for Individual Lifetime Achievement in Patient Safety from the National Quality Forum and The Joint Commission. In 2018, she received the Beau Biden Humanitarian Award from the Patient Safety Movement Foundation. Of more than 50 published works, she has authored two books: Do No Harm and The Quality Advantage and contributed to six major reports from the Lucian Leape Institute on topics of transforming healthcare.

Ms. Morath earned her master's degree in nursing from the University of California, San Francisco and her undergraduate degree from the University of Michigan, Ann Arbor.

As of May 2022, Ms. Morath reported the following external relationships:

Ms. Morath serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

• Lucian Leape Institute, founding and current member, receiving reimbursement for travel expenses.

Ms. Morath also reported work as a consulting member of a workgroup in patient safety in dentistry at the American Dental Association.

Suresh Nair, MD

Dr. Nair is the Physician-in-Chief of the Lehigh Valley Cancer Institute (LVCI) in Allentown, Pennsylvania, and leads the health network’s academic programs. Dr. Nair is the Medical Director of the LVCI membership in the Memorial Sloan Kettering Cancer Center Alliance and has practiced oncology in the community setting for 27 years. He is the initial holder of The Auxiliary of Lehigh Valley Hospital Endowed Chair in Cancer.

With clinical expertise in melanoma, kidney cancer, and immunotherapy, Dr. Nair’s focus is to provide the highest-quality cancer care, including standard and research treatments. He leads a variety of clinical trials at Lehigh Valley Health Network (LVHN) to provide leading-edge options to patients. He leads the high dose interleukin-2 program at LVHN for advanced melanoma and kidney cancer. Dr. Nair started the hematology/oncology fellowship at LVHN and served as the initial Program Director.

Dr. Nair has been a site Principal Investigator in the National Cancer Institute (NCI) Cooperative Group Program for over 25 years and was the first Chair of the NCI Early Phase Central Institutional Review Board. He has been a site Principal Investigator of over 40 T-cell checkpoint inhibitor trials at the LVCI.

Dr. Nair received his medical degree from Jefferson Medical College in Philadelphia, Pennsylvania. He completed his residency at Geisinger Medical Center in Danville, Pennsylvania, and his fellowship at the University of Pittsburgh in Pennsylvania.

As of May 2022, Dr. Nair reported the following external relationships:

Funding for clinical trial support accrual, paid to Lehigh Valley Health Network, from the following companies:

• Bristol-Myers Squibb, for Phase II and Phase III Immuno-Oncology clinical trials.
• Merck, for a Phase III clinical trial for treatment of metastatic renal carcinoma.
• DNAtrix, for a Phase II clinical trial for treatment of glioblastoma.
• Nektar, for Immuno-Oncology clinical trials.

Michael E. Nelson, MD

Dr. Nelson is a practicing physician in Shawnee Mission, Kansas. He is a member of the staff of Shawnee Mission Medical Center, where he has previously served as the Chairman of the Department of Internal Medicine. He is currently the Medical Director of the Sleep Laboratory. His certifications from the American Board of Internal Medicine (ABIM) include Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine. He also holds a certification in Sleep Medicine from the American Board of Sleep Medicine.

Currently, Dr. Nelson serves as a member of the ABIM Council. He is also a member of the Education Committee and the Clinical Practice Committee of the American Thoracic Society (ATS). He has been an active participant in the educational programs of the American College of Physicians and the American College of Chest Physicians (ACCP). Dr. Nelson serves as the Alternate Advisor to the American Medical Association's Current Procedural Terminology Committee for the ACCP and the ATS.

Dr. Nelson earned his medical degree at the University of Kansas School of Medicine in Kansas City. He completed his residency and chief residency in internal medicine, as well as a fellowship in pulmonary and critical care medicine, at the Department of Medicine at the University of Kansas.

As of June 2022, Dr. Nelson reported the following external relationships:

Dr. Nelson serves in significant roles with the following healthcare-related organizations, receiving reimbursement or compensation as listed:

• American College of Chest Physicians, Member, Board of Regents, without compensation. Chair, Health Policy and Advocacy Committee, without compensation. Alternate CPT advisor, without compensation.
• American Thoracic Society, Member, ATS/CHEST Clinical Practice Committee, without compensation. Advisory board, Coding and Billing Quarterly, without compensation. Alternate CPT advisor, without compensation.
• Medical Education Resources, lectures on pulmonary disease and sleep medicine, receiving honorarium and reimbursement for travel expenses.

Jane E. Onken, MD

Dr. Onken is Associate Professor of Medicine, Division of Gastroenterology at Duke University Medical Center in Durham, North Carolina. She is Director of the Inflammatory Bowel Disease Clinic at Duke and on faculty at the Duke Clinical Research Institute. She is board certified in Gastroenterology.

Dr. Onken is Chair of the American Board of Internal Medicine (ABIM) Gastroenterology Board and a member of the ABIM Council. She completed a three-year term as Chair of the Education and Training Committee of the American Gastroenterological Association (AGA). During that term, she served on the AGA’s Leadership Cabinet, the Maintenance of Certification Task Force, and the board of the Academy of Educators. She has chaired the AGA Training Subcommittee and has been a member of the Graduate Training Examination Subcommittee. In 2013, she was selected to join the multi-society Oversight Working Network Committee, a group that designed the Entrustable Professional Activities currently in use by training programs in gastroenterology.

At Duke, she was elected for a fourth term to the University's Academic Council and has served on the Executive Committee of the Academic Council. Dr. Onken is a former program director for the Duke Gastroenterology Fellowship program. She is a member of the Leadership Board of the Triangle Chapter of the Crohn’s and Colitis Foundation of America (CCFA) and is a recipient of the CCFA Premier Physician Award.

Dr. Onken received her undergraduate degree from Smith College in Northampton, Massachusetts, and attended The George Washington University School of Medicine in Washington, DC. She completed her house staff training in internal medicine at Duke University, followed by fellowship training in gastroenterology. She received a master’s degree in health sciences from Duke in 2005.

As of June 2022, Dr. Onken reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Duke University, from the following company:

• Janssen, for a phase II trial in patients with ulcerative colitis, and for a phase III trial for patients with Crohn’s disease.

Dr. Onken serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

• American Gastroenterological Association, Special Section Editor of Education and Training, receiving honoraria.

Work funded by educational grants from industry, paid to Duke University, from the following company:

• Crohn's and Colitis Foundation, for a research grant to explore predictors of extraintestinal manifestations of Irritable Bowel Disease, serving as a Principal Investigator.

John J. Oppenheimer, MD

Dr. Oppenheimer is the Director of Clinical Research at Pulmonary and Allergy Associates as well as Clinical Professor of Medicine at University of Medicine and Dentistry New Jersey-Rutgers in Newark. He is board certified in Internal Medicine and Allergy and Immunology. He trained and was on faculty at the National Jewish Center in Denver, Colorado. Dr. Oppenheimer has participated in over 100 clinical studies with over 200 publications. He serves as the Associate Editor of the Annals of Allergy Asthma and Immunology, co-Section Editor of Current Reports of Allergy and Immunology, Current Opinion of Allergy and Immunology and serves as a reviewer for several journals including the Journal of Allergy and Clinical Immunology and JAMA. He also serves as a member of the American Board of Internal Medicine Council.

He is the past Chairman of the Asthma Diagnosis and Treatment Interest Section as well as the Interest Section Coordinating Committee of the American Academy of Allergy, Asthma and Immunology. He also serves on the Joint Task Force of the Practice Parameter Committee for Allergy Immunology, the writing committee of the Cough Guidelines Committee for the American College of Chest Physicians and is a voting member of Physician Consortium for Performance Improvement and member of the measures development for atopic dermatitis. He was on the Board of Directors of the American Board of Allergy and Immunology (ABAI) 2010-2015 and is the past Chairman of the ABAI. He has focused his career on guideline development and has been actively involved in measurement development in the field of allergy and immunology.

As of April 2022, Dr. Oppenheimer reported the following external relationships:

Preclinical research, with funding for salary support, from the following company:

• AbbVie, for evaluation of potential anaphylaxis.

Funding for clinical trial expenses and staff, paid to Pulmonary and Allergy Associates, P.A., from the following company:

• National Institute of Allergy and Infectious Disease, for a study of dupilumab efficacy based upon IL14 promoter gene polymorphisms.

Attendance at investigators’ meetings, with compensation for travel expenses from the following company:

• Novartis, regarding omalizumab.

Service on data and safety monitoring boards for the following companies, with and honoraria:

• AstraZeneca, Chair of Tezepelumab Adjudication Committee.
• GlaxoSmithKline, regarding mepolizumab.
• Sanofi, regarding dupilumab.

Service on a research-related expert panel or advisory board for the following companies, without compensation:

• GlaxoSmithKline, for advising on a closed triple pivotal trial design.

Work funded by educational grants from industry, paid to Pulmonary and Allergy Associates, P.A, from the following company:

• Sanofi, providing funding for two continuing medical education programs for several asthma.

Work as an author or editor for following company, with compensation as listed:

• UpToDate^®, receiving compensation as an editor.
• American College of Allergy, Asthma & Immunology, receiving compensation as associate editor. Annals of Allergy, Asthma & Immunology.

Rudolph A. Rodriguez, MD

Dr. Rodriguez, a board certified internist and nephrologist, is the Director of the Hospital & Specialty Medicine Service Line at the VA Puget Sound Health Care System and a Professor and Vice Chair of the Department of Medicine at the University of Washington in Seattle. As a clinician scholar, his academic career focused on nephrology fellowship education, along with scholarly work on issues related to vulnerable populations.

Dr. Rodriguez serves as a member of the American Board of Internal Medicine Nephrology Board. He is the Chair of the Veteran Affairs Nephrology Field Advisory Committee. He served on the American Society of Nephrology Training Program Director’s Executive Committee.

Dr. Rodriguez attended Stanford University and earned his medical degree at the Charles Drew/UCLA Medical Education Program at the University of California, Los Angeles. He completed his internal medicine residency at California Pacific Medical Center, and his nephrology fellowship training at the University of California, San Francisco.

As of August 2021, Dr. Rodriguez reported the following external relationships:

Work as an author or editor for following companies, with compensation as listed:

Dr. Rodriguez serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

• Veterans Affairs, serving as Chair, of the Field Advisory Committee, without compensation.

Jorge G. Ruiz, MD, FACP

Dr. Ruiz is Associate Professor of Clinical Medicine and former Director of the University of Miami / Jackson Health System Geriatric Medicine Fellowship in the Division of Geriatrics and Palliative Medicine at the University of Miami Miller School of Medicine in Florida. He is also the Associate Director for Clinical Affairs and Senior Investigator at the Miami VA Geriatric Research, Education, and Clinical Center (GRECC).

Dr. Ruiz has been involved in geriatrics education at the undergraduate, graduate, and continuing professional development levels. Appointed as VA GRECC Associate Director for Clinical Affairs in 2013, he serves in a leadership role in program development that includes a portfolio of innovative clinical demonstration projects related to the care of older adults with frailty and dementia. He is also the Chair of the Miami VA Healthcare System Dementia Committee, Director of the Miami VA Memory Disorders and Falls Prevention Clinics and the leader of the Veterans Successful Aging for Frail Elders program.

His research interests include the study of risks factors for frailty in veterans, the development, implementation and evaluation of care models that aim to reduce the burden of frailty in older Veterans, the use of mesenchymal stem cell therapies to treat aging frailty and Alzheimer's disease, and the development of population-based strategies to prevent dementia. Dr. Ruiz has authored several book chapters and peer-reviewed publications.

Dr. Ruiz is an international medical graduate from the Universidad Peruana Cayetano Heredia, Lima, Peru. He is a fellowship-trained geriatrician, board certified in internal medicine, and geriatric medicine.

As of April 2022, Dr. Ruiz reported the following ongoing external relationships:

Funding for clinical trial expenses and staff, paid to the University of Miami, from the following companies:

• Longeveron

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with honoraria:

• Pfizer

Andrea Russo, MD

Dr. Russo, board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology, is Professor of Medicine at Cooper Medical School of Rowan University, Director of Electrophysiology and Arrhythmia Services, Director of Cardiovascular Research and Director of the Clinical Cardiac Electrophysiology Fellowship Program at Cooper University Hospital in Camden New Jersey. She previously joined the faculty at the University of Pennsylvania in 1997 and then the University of Medicine and Dentistry in New Jersey (UMDNJ)/Robert Wood Johnson Medical School at Cooper University Hospital in Camden, New Jersey in 2009. Dr. Russo serves as Chair of the American Board of Internal Medicine (ABIM) Cardiovascular Disease Board and member of the ABIM Council.  She previously served on the ABIM Cardiovascular Test Writing Committee and the American Board of Medical Specialties Continuing Board Certification Vision for the Future Commission.

She is past President of the Heart Rhythm Society (HRS), member of the HRS Executive Committee, and member of the HRS Board of Trustees. She is also a member of the American Heart Association (AHA) Atrial Fibrillation Systems of Care Advisory Committee and member of the American College of Cardiology (ACC) Cardiovascular Disease in Women Committee. She previously served on or chaired multiple HRS, ACC, or AHA committees, subcommittees or work groups. In addition, she has served as co-Chair or member on several guideline, consensus document, and appropriate use criteria writing groups. Her areas of research interest include implantable cardioverter defibrillators, totally subcutaneous devices, atrial fibrillation, sex differences in arrhythmias, and performance improvement activities.

Dr. Russo earned bachelor's degree in microbiology at the University of Rochester in New York and medical degree at the State University of New York. Health Sciences Center in Syracuse. She completed an internal medicine residency at the Medical College of Pennsylvania in Philadelphia, Pennsylvania, and cardiovascular and electrophysiology fellowships at the University of Medicine and Dentistry New Jersey in Camden, New Jersey.

As of July 2021, Dr. Russo reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Cooper University, from the following companies:

• Boston Scientific
• Kaestra 
• MediLynx

Service on a research-related steering committee for the following companies, without compensation:

• Medtronic
• Apple
• Boston Scientific

Research-related consulting for the following company, with honoraria:

• Medtronic

Work as an author or editor for following company, with compensation as listed:

• UpToDate®, receiving compensation as an editor and author for chapters related to implantable cardioverter defibrillator therapy.

Dr. Russo serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

• Heart Rhythm Society, past President, receiving reimbursement for travel expenses.

Robert Stansbury, MD

Dr. Stansbury is an Associate Professor of Medicine and Director of the West Virginia University (WVU) Sleep Evaluation Center in Morgantown. He is the Sleep Medicine Fellowship Program Director at WVU. He is ABIM board-certified in Pulmonary Disease, Critical Care Medicine, and Sleep Medicine.

He is an active member of the American Thoracic Society and the American Academy of Sleep Medicine and has served in multiple leadership roles including as committee chair for these societies. He is President of the West Virginia Sleep Society and an active member of the West Virginia Rural Health Association.

His research has involved team science and collaboration across multiple institutions. His interest and investigations broadly focus on three main areas: rural health inequity, novel approaches to the diagnosis and management of sleep apnea, and the physiology of occupational lung disease. Dr. Stansbury has published multiple research and review articles in these domains and multiple books chapters focused on sleep medicine and occupational lung disease.

Dr. Stansbury earned his medical degree at WVU School of Medicine and completed his internal medicine residency at the University of Kentucky College of Medicine in Lexington, Kentucky. He completed his pulmonary and critical care fellowship at WVU and his sleep medicine fellowship at the University of Pittsburgh School of Medicine in Pennsylvania.

As of November 2021, Dr. Stansbury reported the following external relationships:

Work as an author or editor for following companies, with compensation as listed:

• Elsevier, Book Chapter in Principles and Practice Sleep Medicine.

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with honoraria:

• Resmed

Dr. Stansbury serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

• American Thoracic Society, Quality Improve and Implementation Committee, SRN Assembly Executive Committee, Chair Sleep and Respiratory Neurobiology Web Committee, without compensation.
• American Society of Sleep Medicine, Chair Sleep Technologist and Respiratory Therapist Education Committee, without compensation.

Lynn T. Tanoue, MD, MBA

Dr. Tanoue is board certified in Internal Medicine, Pulmonary Diseases, and Critical Care Medicine. She is Professor of Medicine in the Section of Pulmonary, Critical Care, and Sleep Medicine, and Vice-Chair for Clinical Affairs in the Department of Internal Medicine at Yale School of Medicine in New Haven, Connecticut. She directs the Yale Screening and Nodule Program at Smilow Cancer Hospital at Yale-New Haven, co­directs the Yale Thoracic Oncology Program, and is the principal investigator of the Yale Lung Cancer Biorepository. Her academic focus is in the field of thoracic oncology.

Dr. Tanoue is a member of the American Board of Internal Medicine's Council, and is currently chair of the American Thoracic Society Thoracic Oncology Assembly. She has served in leadership roles in the American College of Chest Physicians and the National Association for the Medical Direction of Respiratory Care. She serves on numerous committees at her home institutions, including as a member of the governing Board of Yale Medicine, and as immediate pastPresident of the medical staff of Yale New Haven Hospital. Dr. Tanoue is currently President of the Board of Directors of the Yale Medical Symphony Orchestra.

Dr. Tanoue received her bachelor’s degree from Harvard University and medical degree from Yale School of Medicine. She did her internal medicine residency, chief residency and fellowship in pulmonary/critical care medicine at Yale-New Haven Hospital. Dr. Tanoue received her master's degree in business administration from Yale School of Management.

As of July 2021, Dr. Tanoue reported the following external relationships:

Work as an author or editor for the following companies, with compensation as listed:

• UpToDate^®
• Elsevier, receiving compensation as an Editor of Year Book of Pulmonary Disease.

Dr. Tanoue serves in significant roles with the following healthcare-related organization, receiving reimbursement or compensation as listed:

• American Thoracic Society, Chair, Thoracic Oncology Assembly, receiving reimbursement for travel expenses.
• American College of Chest Physicians, faculty, receiving honoraria and reimbursement for travel expenses.

Mark M. Udden, MD

Dr. Udden, a board-certified hematologist and internist, is Chief of Benign Hematology and Professor of Medicine at Baylor College of Medicine in Houston, Texas. He is Chief of Hematology at the Ben Taub General Hospital and Harris Health Smith Clinic. He is also Attending Physician in the Baylor Clinic and consults at Baylor Saint Luke’s Medical Center and the Texas Children’s Hospital Pavilion for Women. He has a special interest in sickle cell disease and hematology of pregnancy. He also co-chairs the second-year medical student course in hematology/oncology and has an active teaching role for resident and fellowship training at Baylor.

He has served at Baylor as Core Clerkship Director for Internal Medicine from 1990 to 2007 and Chairman of the Longitudinal Ambulatory Care Experience course from 1994 to 1999. He was an Adjunct Assistant then Associate Professor, in the Biomedical Engineering Department at Rice University in Houston from 1983 until 1992.

Dr. Udden is Chair of the American Board of Internal Medicine (ABIM) Hematology Board. He is also Chair of the ABIM Hematology Board Exam Committee. He is a fellow of the American College of Physicians. At Baylor, he has received numerous teaching awards including the Barbara and Corbin J. Robertson, Jr. Presidential Award for Excellence in Education in 2008 and the Master Clinician Lifetime Award in 2013.

He received his undergraduate degree from the Massachusetts Institute of Technology in Cambridge and his medical degree from The University of Texas Southwestern Medical School in Dallas. He completed his residency in internal medicine and a fellowship in hematology at Baylor College of Medicine.

As of August 2022, Dr. Udden reported the following external relationships:

Dr. Udden serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

• American Society of Hematology, participating in Work Force Summit and Committee for Hematology-Focused Fellowship, receiving reimbursement for travel expenses.

Dr. Udden also reported compensation for medical legal consulting, with a portion paid to Baylor College of Medicine.